Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - PA: CIHR/Rx&D - CAMO Research Program

McMaster University

$27,500.00

Assessment of health care patterns for elderly lung cancer patients in southern Ontario.

FY 2011-12

Summary
The elderly population, defined as those older than 65 years of age, is growing in Canada, with the number of seniors in Canada expected to more than double between 2005 and 2036. Recent Canadian statistics show that 43% of new cancers in 2010 were diagnosed in those older than 70 years. With no change in this distribution we can expect a rapidly increasing number of cancer cases in the elderly as "baby boomers" age. Lung cancer is the leading cause of cancer-related death and half of lung cancers are diagnosed in patients over 70 years old. Unfortunately, elderly cancer patients have not been well represented in clinical trials, so there is less guidance for how to treat them, although, the few available trials have shown that chemotherapy helps elderly lung cancer patients. How many physicians are applying these findings to their daily practice is unclear. Decision-making about chemotherapy is also complicated by age-related changes in organ function, which leads to an increased risk of dangerous side effects from treatment and makes it harder to predict the degree of benefit in an individual. With the expected increase in numbers, we need to better understand how we are currently treating elderly lung cancer patients to both improve their outcomes and plan resources in the future. We propose a project that will improve our understanding of care for elderly cancer patients and what influences their survival. By examining data the Ontario Cancer Registry, Institute for Clinical Evaluative Sciences (ICES), and patient charts from three periods over the last 20 years, we can determine the factors that influence referral to receive treatment, whether or not a patient receives chemotherapy, and how long they survive. Changes in proportion of elderly lung cancer patients receiving chemotherapy will show if trial data are applied in daily practice. We will also create a tool to help predict survival, valuable information in discussions about treatment every day.
Program
Fellowship - PA: CIHR/Rx&D - CAMO Research Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
243287
Name
Dawe David
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Medical Oncologists (Ottawa)
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Health Research Training B - HP
Projecttitle
Assessment of health care patterns for elderly lung cancer patients in southern Ontario.
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,500
Cihrequipment2
$0
Programname2
Fellowship - PA: CIHR/Rx&D - CAMO Research Program
Keyworddelim
Chemotherapy; Elderly; Geriatric Oncology; Lung Cancer; Practice Pattern; Prognosis
Abstract
The elderly population, defined as those older than 65 years of age, is growing in Canada, with the number of seniors in Canada expected to more than double between 2005 and 2036. Recent Canadian statistics show that 43% of new cancers in 2010 were diagnosed in those older than 70 years. With no change in this distribution we can expect a rapidly increasing number of cancer cases in the elderly as "baby boomers" age. Lung cancer is the leading cause of cancer-related death and half of lung cancers are diagnosed in patients over 70 years old. Unfortunately, elderly cancer patients have not been well represented in clinical trials, so there is less guidance for how to treat them, although, the few available trials have shown that chemotherapy helps elderly lung cancer patients. How many physicians are applying these findings to their daily practice is unclear. Decision-making about chemotherapy is also complicated by age-related changes in organ function, which leads to an increased risk of dangerous side effects from treatment and makes it harder to predict the degree of benefit in an individual. With the expected increase in numbers, we need to better understand how we are currently treating elderly lung cancer patients to both improve their outcomes and plan resources in the future. We propose a project that will improve our understanding of care for elderly cancer patients and what influences their survival. By examining data the Ontario Cancer Registry, Institute for Clinical Evaluative Sciences (ICES), and patient charts from three periods over the last 20 years, we can determine the factors that influence referral to receive treatment, whether or not a patient receives chemotherapy, and how long they survive. Changes in proportion of elderly lung cancer patients receiving chemotherapy will show if trial data are applied in daily practice. We will also create a tool to help predict survival, valuable information in discussions about treatment every day.
Competitiondate
201110
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dawe, David
Approvedterm
1 an 0 mois
Cihrcontribution2
Patient Oriented Research~ $27,500~ $0~